ClearanceBrief
Recall Z-2439-2023 ยท QOF Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

BioFire Diagnostics, LLC

BioFire Respiratory Panel 2.1 (RP2.1), REF: 423742, For FILMARRAY systems, IVD, Rx Only

DateAug 21, 2023 (initiated May 8, 2023)
StatusOpen, Classified
ReasonDue to manufacturing issue, panels may result in false negative results.
Root causeProcess design
ActionBetween the dates of May 8, 2023 - May 11, 2023, Biomerieux ( Parent company of BioFire Diagnostics, LLC) issued an "Urgent: Medical Device Correction" notification to affected consignees via FedEx. Biomerieux asked consignees to take the following actions: 1. Immediately examine your inventory for product identified in this recall (refer to Table 1). 2. Discontinue use and discard any remaining product in your possession that is subject to this recall. bioMerieux will replace the product at no charge in accordance with BIOFIRE s standard limited warranty. 3. Please complete the accompanyi
Quantity705 kits (30 pouches/kit)
DistributionUS: CA CO CT FL GA IA IL IN LA MA MI MO MT NC NE NJ NM NY OH OK PA TN UT WV OUS: Canada, India, Japan, Singapore, Colombia
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.